Medicinal Plants and Bioactive Compounds
Medicinal Plants and Bioactive Compounds is a research topic within Molecular Biology. Science Explorer counts 9.3k research works in it since 1950. 15.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the traditional use, chemical composition, pharmacology, and clinical efficacy of Rhodiola rosea and its active compound Salidroside. The research covers a wide range of topics including neuroprotective effects, stress management, antioxidant activity, and the potential therapeutic applications of Rhodiola rosea in treating conditions such as depression. It also explores the pharmacological studies and medicinal properties of this herbal medicine.
- Rhodiola Rosea
- Salidroside
- Adaptogens
- Neuroprotective Effects
- Stress Management
- Antioxidant Activity
- Pharmacological Studies
- Medicinal Plants
- Depression Treatment
- Herbal Medicine
- Research works
- 9.3k fractional, since 1950
- In the world top 10%
- 1.4k per year above
- Top-10% rate
- 15.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +55% the tick is no change
Which countries lead Medicinal Plants and Bioactive Compounds research?
By volume, China and India publish the most (919 and 338 works in 2022–2025).
By volume, 2022–2025
- 1 China 919 works
- 2 India 338 works
- 3 United States 151 works
- 4 Russia 123 works
- 5 Iran 95 works
- 6 Türkiye 55 works
- 7 South Korea 53 works
- 8 Poland 46 works
- 9 Egypt 45 works
- 10 Ukraine 37 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Medicinal Plants and Bioactive Compounds research?
By volume in 2022–2025, Chengdu University of Traditional Chinese Medicine publishes the most Medicinal Plants and Bioactive Compounds research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Beijing University of Chinese Medicine.
By volume, 2022–2025
- 1 Chengdu University of Traditional Chinese MedicineChina 26 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 20 works
- 3 Beijing University of Chinese MedicineChina 16 works
- 4 Shanghai University of Traditional Chinese MedicineChina 13 works
- 5 Nanjing University of Chinese MedicineChina 13 works
- 6 Shandong University of Traditional Chinese MedicineChina 10 works
- 7 National Institute of AyurvedaIndia 10 works
- 8 Guangzhou University of Chinese MedicineChina 10 works
- 9 First Affiliated Hospital of Henan UniversityChina 10 works
- 10 Anhui University of Traditional Chinese MedicineChina 10 works
Where is Medicinal Plants and Bioactive Compounds research done?
The largest centres of Medicinal Plants and Bioactive Compounds research in 2022–2025 are Beijing (China), Guangzhou (China), Chengdu (China) and Shanghai (China).
Where is the best place to study Medicinal Plants and Bioactive Compounds?
Among universities, judged by research, Chengdu University of Traditional Chinese Medicine, Mashhad University of Medical Sciences and Shanghai University of Traditional Chinese Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chengdu University of Traditional Chinese MedicineChina | 82.2 | 37.6% | 48.8× | 26 | +52.9% |
| 2 | Mashhad University of Medical SciencesIran | 73.6 | 34.6% | 14.4× | 8 | +190.4% |
| 3 | Shanghai University of Traditional Chinese MedicineChina | 64.9 | 32.4% | 27.9× | 13 | +22.6% |
| 4 | Beijing University of Chinese MedicineChina | 64.2 | 25.2% | 39.2× | 16 | +40.7% |
| 5 | Anhui University of Traditional Chinese MedicineChina | 60.0 | 24.8% | 42.7× | 10 | +132.0% |
| 6 | Zhejiang Chinese Medical UniversityChina | 59.9 | 37.9% | 14.5× | 9 | -12.6% |
| 7 | Tianjin University of Traditional Chinese MedicineChina | 57.2 | 34.9% | 39.8× | 10 | -33.7% |
| 8 | Guangzhou University of Chinese MedicineChina | 56.6 | 27.4% | 21.9× | 10 | +17.4% |
| 9 | Shandong University of Traditional Chinese MedicineChina | 53.8 | 29.3% | 34.2× | 10 | -32.4% |
| 10 | Nanjing University of Chinese MedicineChina | 53.5 | 23.4% | 21.3× | 13 | -28.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Medicinal Plants and Bioactive Compounds research growing?
Output in 2018–2022 was 55% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Medicinal Plants and Bioactive Compounds.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.